Conference Coverage

Managing Obesity Can Lead to Sarcopenia: A ‘Hidden’ Problem


 

Prevention and Recommendations

Exercise and nutrition are two key components in the prevention and management of sarcopenic obesity. Physicians prescribing GLP-1 receptor agonists “must also counsel patients about incorporating aerobic exercise and resistance training as part of the treatment plan, as well as ensuring they eat a high-protein diet,” Yoon Ji Ahn, MD, and Vibha Singhal, MD, MPH, of the Weight Management Center of Massachusetts General Hospital in Boston, wrote in a commentary published by this news organization.

Paraguayan nutritionist Patricia López Soto, a diabetes educator with postgraduate degrees in obesity, diabetes, and bariatric surgery from Favaloro University in Buenos Aires, shared with this news organization the following general recommendations to prevent sarcopenic obesity in patients undergoing weight loss treatment:

  • Follow a healthy and balanced Mediterranean or DASH-style diet.
  • Increase protein intake at the three to four main meals to a minimum of 1.4-1.5 g/kg/day.
  • Try to make the protein intake mostly of high biological value: Beef, chicken, fish, eggs, seafood, cheese, skim milk, and yogurt.
  • Ensure protein intake at each meal of between 25 g and 30 g to increase protein synthesis. For example, a 150 g portion of meat or chicken provides 30 g of protein.
  • If the protein intake is not achieved through food, a supplement measure like isolated and hydrolyzed whey protein is a good option.
  • Engage in strength or resistance training (weightlifting) three to four times per week and 30 minutes of cardiovascular exercise every day.
  • To improve adherence, treatment should be carried out with a multidisciplinary team that includes a physician, nutritionist, and physical trainer, with frequent check-ups and body composition studies by bioimpedance.

Dr. Romero and Ms. López declared no relevant financial relationships.

This story was translated from the Medscape Spanish edition using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication. A version of this article appeared on Medscape.com.

Pages

Recommended Reading

Endoscopic Sleeve Gastroplasty More Cost-Effective Long Term Than Semaglutide for Treating Obesity
MDedge Endocrinology
Sugar Substitutes Satisfy Appetite, Blunt Insulin Response
MDedge Endocrinology
The Fascinating Way to Measure Glucose With a Phone’s Compass
MDedge Endocrinology
Eli Lilly to Ask FDA to Approve Weight Loss Drug for Sleep Apnea
MDedge Endocrinology
Temporary Gut Liner Lowers Weight, A1c
MDedge Endocrinology
Are Carbs Really the Enemy?
MDedge Endocrinology
Semaglutide Trial for Knee Osteoarthritis Shows Improvements in Pain, Physical Function
MDedge Endocrinology
GLP-1 Receptor Agonists: Which Drug for Which Patient?
MDedge Endocrinology
Evening May Be the Best Time for Exercise
MDedge Endocrinology
Pancreatic Fat Is the Main Driver for Exocrine and Endocrine Pancreatic Diseases
MDedge Endocrinology